Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stool bulk formation refers to the process of increasing stool mass and water content, usually mediated by dietary fiber or bulk-forming laxatives such as psyllium, methylcellulose, and polycarbophil. These agents are not digested and absorb water within the intestine, expanding to form soft, bulky stools that stimulate bowel contractions and promote regular defecation. The physiological mechanism is not associated with a specific molecular receptor, enzyme, or transport protein but rather is a physical effect on stool properties and colon motility. This category is considered very safe for long-term use, but may occasionally cause bloating, gas, or—if insufficient fluids are consumed—bowel obstruction[3][5][6][7][8][9][10].
Absorbing water into the stool to increase volume and softness; Stimulating colonic peristalsis through increased bulk
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stool bulk formation.